Mitsubishi UFJ Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $126M | Buy |
1,394,217
+82,649
| +6% | +$6.92M | 0.07% | 237 |
|
|
2026
Q1 | $105M | Buy |
1,311,568
+83,001
| +7% | +$6.84M | 0.07% | 235 |
|
|
2025
Q4 | $105M | Buy |
1,228,567
+63,266
| +5% | +$5.19M | 0.07% | 221 |
|
|
2025
Q3 | $90.6M | Buy |
1,165,301
+52,700
| +5% | +$4.12M | 0.07% | 239 |
|
|
2025
Q2 | $87M | Buy |
1,112,601
+65,337
| +6% | +$4.87M | 0.07% | 233 |
|
|
2025
Q1 | $75.9M | Buy |
1,047,264
+95,750
| +10% | +$6.85M | 0.07% | 237 |
|
|
2024
Q4 | $70.3M | Buy |
951,514
+58,352
| +7% | +$4.08M | 0.07% | 225 |
|
|
2024
Q3 | $58.9M | Buy |
893,162
+96,190
| +12% | +$6.99M | 0.06% | 252 |
|
|
2024
Q2 | $73.6M | Buy |
796,972
+88,055
| +12% | +$7.8M | 0.09% | 182 |
|
|
2024
Q1 | $67.7M | Buy |
708,917
+110,591
| +18% | +$9.29M | 0.09% | 186 |
|
|
2023
Q4 | $43.8M | Buy |
598,326
+38,345
| +7% | +$2.67M | 0.08% | 219 |
|
|
2023
Q3 | $38.8M | Buy |
559,981
+43,770
| +8% | +$3.52M | 0.08% | 208 |
|
|
2023
Q2 | $48.7M | Buy |
516,211
+20,058
| +4% | +$1.74M | 0.1% | 166 |
|
|
2023
Q1 | $41M | Buy |
496,153
+54,222
| +12% | +$4.26M | 0.1% | 173 |
|
|
2022
Q4 | $32.8M | Buy |
441,931
+47,154
| +12% | +$3.63M | 0.09% | 195 |
|
|
2022
Q3 | $32.6M | Buy |
394,777
+35,525
| +10% | +$3.42M | 0.11% | 163 |
|
|
2022
Q2 | $34.2M | Buy |
359,252
+29,174
| +9% | +$3.02M | 0.15% | 140 |
|
|
2022
Q1 | $38.9M | Buy |
330,078
+27,642
| +9% | +$3.1M | 0.15% | 131 |
|
|
2021
Q4 | $38.8M | Buy |
302,436
+43,404
| +17% | +$5.06M | 0.15% | 131 |
|
|
2021
Q3 | $29.3M | Buy |
259,032
+22,342
| +9% | +$2.55M | 0.14% | 137 |
|
|
2021
Q2 | $24.5M | Buy |
236,690
+29,839
| +14% | +$2.81M | 0.13% | 156 |
|
|
2021
Q1 | $17.3M | Buy |
206,851
+21,830
| +12% | +$1.85M | 0.11% | 192 |
|
|
2020
Q4 | $16.9M | Buy |
185,021
+9,994
| +6% | +$829K | 0.13% | 165 |
|
|
2020
Q3 | $14M | Buy |
175,027
+24,614
| +16% | +$1.92M | 0.13% | 162 |
|
|
2020
Q2 | $10.4M | Buy |
150,413
+20,504
| +16% | +$1.46M | 0.12% | 178 |
|
|
2020
Q1 | $8.17M | Sell |
129,909
-1,173
| -0.9% | -$84.6K | 0.13% | 166 |
|
|
2019
Q4 | $10.1M | Buy |
131,082
+16,005
| +14% | +$1.25M | 0.13% | 165 |
|
|
2019
Q3 | $8.44M | Buy |
115,077
+4,590
| +4% | +$322K | 0.14% | 153 |
|
|
2019
Q2 | $6.8M | Buy |
110,487
+20,949
| +23% | +$1.27M | 0.12% | 179 |
|
|
2019
Q1 | $5.71M | Buy |
89,538
+6,654
| +8% | +$380K | 0.12% | 169 |
|
|
2018
Q4 | $3.97M | Sell |
82,884
-7,635
| -8% | -$386K | 0.1% | 200 |
|
|
2018
Q3 | $5.25M | Sell |
90,519
-1,779
| -2% | -$87K | 0.11% | 188 |
|
|
2018
Q2 | $4.48M | Buy |
92,298
+3,900
| +4% | +$182K | 0.1% | 211 |
|
|
2018
Q1 | $4.11M | Sell |
88,398
-9,804
| -10% | -$426K | 0.1% | 219 |
|
|
2017
Q4 | $3.75M | Buy |
98,202
+4,227
| +4% | +$155K | 0.08% | 255 |
|
|
2017
Q3 | $3.42M | Buy |
93,975
+2,400
| +3% | +$91.5K | 0.08% | 255 |
|
|
2017
Q2 | $3.61M | Sell |
91,575
-11,397
| -11% | -$416K | 0.09% | 237 |
|
|
2017
Q1 | $3.23M | Sell |
102,972
-4,638
| -4% | -$145K | 0.07% | 284 |
|
|
2016
Q4 | $3.43M | Sell |
107,610
-5,283
| -5% | -$171K | 0.08% | 254 |
|
|
2016
Q3 | $4.54M | Buy |
112,893
+16,869
| +18% | +$635K | 0.11% | 190 |
|
|
2016
Q2 | $3.19M | Buy |
96,024
+2,103
| +2% | +$72K | 0.08% | 251 |
|
|
2016
Q1 | $2.76M | Buy |
93,921
+8,235
| +10% | +$227K | 0.07% | 271 |
|
|
2015
Q4 | $2.26M | Buy |
85,686
+4,392
| +5% | +$114K | 0.07% | 300 |
|
|
2015
Q3 | $1.93M | Sell |
81,294
-258
| -0.3% | -$6.23K | 0.06% | 320 |
|
|
2015
Q2 | $1.94M | Sell |
81,552
-4,668
| -5% | -$105K | 0.06% | 347 |
|
|
2015
Q1 | $2.05M | Sell |
86,220
-4,026
| -4% | -$90.3K | 0.06% | 349 |
|
|
2014
Q4 | $1.92M | Sell |
90,246
-11,586
| -11% | -$233K | 0.06% | 349 |
|
|
2014
Q3 | $1.73M | Sell |
101,832
-21,942
| -18% | -$346K | 0.05% | 392 |
|
|
2014
Q2 | $1.77M | Sell |
123,774
-4,008
| -3% | -$54.3K | 0.05% | 423 |
|
|
2014
Q1 | $1.58M | Buy |
127,782
+4,800
| +4% | +$55.4K | 0.04% | 455 |
|
|
2013
Q4 | $1.38M | Sell |
122,982
-33,120
| -21% | -$373K | 0.04% | 485 |
|
|
2013
Q3 | $1.81M | Buy |
156,102
+7,902
| +5% | +$92.4K | 0.05% | 433 |
|
|
2013
Q2 | $1.66M | Buy |
+148,200
| New | +$1.75M | 0.05% | 436 |
|
Other funds holding EW
Mitsubishi UFJ Asset Management's EW Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Edwards Lifesciences (EW) stake by 6.3% in Q2 2026, buying an estimated $6.92M and bringing the position to 1,394,217 shares worth $126M. The position accounts for 0.07% of the portfolio, ranked #237.
Mitsubishi UFJ Asset Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Mitsubishi UFJ Asset Management held 1,394,217 shares of Edwards Lifesciences worth $126M as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 82,649 Edwards Lifesciences shares in Q2 2026, an estimated $6.92M.
- Edwards Lifesciences made up 0.07% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #237 holding.
- Mitsubishi UFJ Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.